Status:
COMPLETED
ED90 for Hyperbaric Bupivacaine in Super Obese Parturients
Lead Sponsor:
Duke University
Conditions:
Obesity, Morbid
Spinal Anesthesia
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.
Eligibility Criteria
Inclusion
- American Society of Anesthesiology (ASA) class 2 and 3
- English speaking
- Gestational age \> 36 weeks
- Scheduled for cesarean delivery under combined spinal epidural anesthesia
- 18 years or older
- BMI \> 50 kg/m2
Exclusion
- History of past or current intravenous drug or chronic opioid abuse
- Allergy or contraindication to any study medications
- Intrapartum cesarean delivery under epidural anesthesia
- Cesarean delivery under general anesthesia
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 6 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03781388
Start Date
May 1 2019
End Date
December 6 2022
Last Update
February 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Hospital
Durham, North Carolina, United States, 27705